ArticleThe Journal of urology2022

Prostate-Specific Membrane Antigen Is a Biomarker for Residual Disease following Neoadjuvant Intense Androgen Deprivation Therapy in Prostate Cancer.

John R Bright et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.